ISTH Webinar · USE OF NOVEL DRUGS IN HEMOPHILIA

5 de agosto de 2020 · 13:00 h UTC/GTM

Nicola Curry «Extended half-life replacement therapies»

Learning objectives:

By the end of the webinar participants will be familiar with:

• the different methods for extending the half life of factor concentrates
• the pros and cons of these treatments
• the future role of these treatments within the landscape of haemophilia treatments

Margaret Ragni «Non-replacement therapies»

Learning Objectives:

• To identify the gaps and shortcomings of current factor therapies
• To describe current approaches to manipulating the coagulation cascade to promote hemostasis
• To understand the mechanism, safety, and efficacy of novel non-factor therapies, emicizumab, fitusiran, and concizumab

REGISTRO | MÁS INFORMACIÓN